alzheimer's

View All

Potential of Cannabidiol (CBD) as a Treatment Substance
Can Cannabinoids be an Effective Medicinal Substance?

Cannabidiol (CBD) is one of the 120 cannabinoids present naturally in cannabis plants. After tetrahydrocannabinol (THC), Cannabidiol is the second most prevalently available cannabinoid. Cannabidiol, an important component of medicinal marijuana, is either directly from the hemp plant or synthesized in a laboratory...

Find More

marijuana-to-treat-Alzheimer's
Can Alzheimer’s be cured with Marijuana?

Alzheimer's is a progressive brain disorder that results in the degeneration of brain cells. It affects the thinking, reasoning, memory, and problem-solving skills of the person. Apart from cognitive function, it also influences mood, personality, behavior, and social skills. In the advanced stages, the patients ar...

Find More

Alzheimer-Disease-Risk-Factors
The Question That Remains Unanswered: What Might Be Causing Alzheimer’s?

50 million people globally have dementia, and out of all the dementia cases, Alzheimer’s Disease accounts for about 60–70% of cases, says the WHO. Alzheimer's Disease is a neurodegenerative disease, a common cause of dementia that affects behavior, memory, and thinking abilities of an individual. Mostly the symptom...

Find More

Technology-and-Alzheimer’s
When Technological Innovations Help in Remembering for People Living with Alzheimer’s

Alzheimer's is a progressive neurological disorder associated with the degeneration of brain cells with time. As the disease progresses it causes severe impact on the memory, thinking, and overall behavior of the individual, at the later phases it becomes even challenging to perform simple day to day tasks.  ...

Find More

What are the 10 early signs of Alzheimer’s that are overlooked?

Alzheimer’s is a brain disease, associated with the degeneration of brain cells. It is an irreversible and progressive disease that generally affects people aged above 65 years but in very rare cases, early-onset has also been noticed in the late ’40s. The AD affects memory, reasoning and cognitive skills of the pe...

Find More

Alzheimer’s-Disease-Market-Scenario
An Ageing Population and Upcoming Therapies: What is shaping the Alzheimer’s Disease Market Scenario?

The ageing population is a global phenomenon. According to the UN’s “World Population Prospects 2019” by 2100, the world’s population is projected to reach approximately 10.9 billion. Moreover, between 2020 and 2100, the number of people ages 80 and older is expected to increase from 146 million to 881 million. ...

Find More

Alzheimer
World Alzheimer’s Day

World Alzheimer’s Day World Alzheimer’s Day takes place on 21 September of every year. World Alzheimer's Day is a campaign to raise awareness and highlight issues faced by people those who are affected by dementia. The exact cause of Alzheimer's disease is not known, although several things are considered to ...

Find More

alzheimer and menopause
What is the link between Alzheimer’s and Menopause?

Alzheimer is known to affect an estimated 50 million people worldwide. There is no doubt that this number is going to reach 75 million in 2030 and 131.5 million in 2050 of all age group worldwide. Among affected 5.5 million people aged 65 and older with Alzheimer's in the United States, 3.4 million were reported wo...

Find More

Johnson & Johnson
Notizia

If dementia genes are found, drug discovery can be accelerated in brain disorders The overproduction of a protein called tau has been detected in the neuron degeneration that causes Alzheimer’s and other forms of dementia. But the exact genetic process that causes tau is still a mystery. Scientists of the University...

Find More

Therapeutics and Celgene to develop therapies; Takeda’s expansion; J&J hopes to limit; Tech Prize for genome sequencing; Endocyte’s late-stage prostate cancer deal

Strategic Immunology Alliance partners Nimbus Therapeutics and Celgene to develop therapies for Autoimmune Disorders A biotechnology company involved in the development of drugs and therapies through computational expertise announced on October 3 that they are entering into a long-term strategic alliance with Celgen...

Find More